Traditional diagnosis of Mycobacterial infections depends upon smear positivity in sputum samples, culture and chest radiography. For rapid diagnosis, nucleic acid amplification tests such as polymerase chain reaction (PCR), immune-based assays such as enzyme-linked immunosorbent assay (ELISA), skin patch test and rapid culture systems are performed.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Mycobacterium Tuberculosis Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Mycobacterium Tuberculosis Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Mycobacterium Tuberculosis Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Albert Einstein College of Medicine
- Aldatu Biosciences Inc
- All India Institute of Medical Sciences
- Ayanda Biosystems SA (Inactive)
- BioHelix Corp
- Biological Dynamics Inc
- bioMerieux SA
- Biopromic AB
- Biotec Laboratories Ltd
- Burnet Institute
- CellCarta Biosciences Inc
- Ceres Nanosciences Inc
- CHIP Diagnostics Inc
- Chronus Pharmaceuticals Inc
- Co-Diagnostics Inc
- CoSara Diagnostics Pvt Ltd
- Diagnorite Innovative Healthcare Pvt Ltd
- DNA Medicine Institute (DMI) Inc
- eBiogen Limited
- Emory University
- EMPE Diagnostics AB
- Genome Diagnostics Pvt Ltd
- Great Basin Scientific Inc.
- Intelligent OMICS Ltd
- IPI Singapore
- Johns Hopkins University
- LifeArc
- Luminex Corp
- LumiraDx Ltd
- Master Diagnostica Sociedad Limitada
- MedNostic Technologies, LLC
- MiCo BioMed Co Ltd
- MND Diagnostic LTD
- Mologic Ltd
- NextGen Invitro Diagnostics Pvt Ltd
- Nipro Corp
- North-West University
- Omniome Inc
- OPKO Health Inc
- Oregon Health & Science University
- Panagene Inc
- PixCell Medical Technologies Ltd
- ProKyma Technologies Ltd
- Pulmonescence Diagnostics Inc
- Qiagen NV
- Queen Mary University of London
- Rutgers The State University of New Jersey
- Seegene Inc
- Senzo Inc
- SomaLogic Inc
- SpeeDx Pty Ltd
- SSI Diagnostica
- Stanford University
- Statens Serum Institut
- Stellar Diagnostics India Pvt Ltd
- The Forsyth Institute
- The Francis Crick Institute Ltd
- Tulane University School of Medicine
- Unitaq Bio, Inc
- University College London
- University of California San Diego
- University of California San Francisco
- University of Cape Town
- University of Minnesota
- University of Notre Dame
- University of Otago
- University of Strathclyde
- Viti, Inc.
- Wave 80 Biosciences Inc

